FOLH1 and posterior cortical atrophy: The main limitation of this study is the small number of patients and the known inhomogeneity of PCa (e.g., Gleason score, PSA at surgery) which makes a comparison to the results with other traces like 111In-labeled PSMA ligands [23] difficult.